The effect of cytostatic therapy on cellular immunity in vitro.
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001402:B-Lymphocytes; D003520:Cyclophosphamide / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D037102:Lectins / Q000494:pharmacology; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D013601:T-Lymphocytes; D014747:Vinblastine / Q000009:adverse effects
D000970:Antineoplastic Agents; D037102:Lectins; D014747:Vinblastine; D003520:Cyclophosphamide; D008727:Methotrexate